Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Krapf

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1976
Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblastsH Warnatz, F Krapf
Zeitschrift Fur Rheumatologie|September 1, 1991
[Plasma nucleic acids and their possible pathophysiologic significance in systemic lupus erythematosus]J R Kalden, F Krapf
Clinical and Experimental Immunology|March 1, 1989
Antibody binding of macromolecular DNA and RNA in the plasma of SLE patientsF Krapf, M Herrmann, W Leitmann, et al.
Rheumatology International|January 1, 1991
Pathogenesis of SLE: immunopathology in manJ R Kalden, T H Winkler, M Herrmann, et al.
Rheumatology International|January 1, 1989
C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseasesC Huber, A Rüger, M Herrmann, et al.
Clinical and Experimental Rheumatology|April 1, 1985
The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case reportF Krapf, B Manger, B Koch, et al.
Journal of Clinical & Laboratory Immunology|December 1, 1986
Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assaysF Krapf, C Fuchs, M Herrmann, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Circulating immune complexes in malignant diseases increased detection rate by simultaneous use of three assay methodsF Krapf, D Renger, I Schedel, et al.
Deutsche Medizinische Wochenschrift (1946)|August 31, 1984
[Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]G Heptner, S Domschke, F Krapf, et al.
Molecular and Cellular Probes|February 1, 1990
Monoclonal antibodies directed against the rev protein of human immunodeficiency virus type 1R Voll, C Aepinus, F Krapf, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1976
Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblastsH Warnatz, F Krapf
Zeitschrift Fur Rheumatologie|September 1, 1991
[Plasma nucleic acids and their possible pathophysiologic significance in systemic lupus erythematosus]J R Kalden, F Krapf
Clinical and Experimental Immunology|March 1, 1989
Antibody binding of macromolecular DNA and RNA in the plasma of SLE patientsF Krapf, M Herrmann, W Leitmann, et al.
Rheumatology International|January 1, 1991
Pathogenesis of SLE: immunopathology in manJ R Kalden, T H Winkler, M Herrmann, et al.
Rheumatology International|January 1, 1989
C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseasesC Huber, A Rüger, M Herrmann, et al.
Clinical and Experimental Rheumatology|April 1, 1985
The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case reportF Krapf, B Manger, B Koch, et al.
Journal of Clinical & Laboratory Immunology|December 1, 1986
Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assaysF Krapf, C Fuchs, M Herrmann, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Circulating immune complexes in malignant diseases increased detection rate by simultaneous use of three assay methodsF Krapf, D Renger, I Schedel, et al.
Deutsche Medizinische Wochenschrift (1946)|August 31, 1984
[Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]G Heptner, S Domschke, F Krapf, et al.
Molecular and Cellular Probes|February 1, 1990
Monoclonal antibodies directed against the rev protein of human immunodeficiency virus type 1R Voll, C Aepinus, F Krapf, et al.
Pageof 2